To replicate or not to replicate: the case of pharmacogenetic studies: Establishing validity of pharmacogenomic findings: from replication to triangulation

Circ Cardiovasc Genet. 2013 Aug;6(4):409-12; discussion 412. doi: 10.1161/CIRCGENETICS.112.000010.
No abstract available

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / genetics
  • Clinical Competence
  • Genome-Wide Association Study
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Pharmacogenetics*
  • Polymorphism, Single Nucleotide
  • Reproducibility of Results

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors